Neutrophil elastase inhibitor prevents ischemic brain damage via reduction of vasogenic edema (Q43059165)

13 November 2017

Neutrophil elastase inhibitor prevents ischemic brain damage via reduction of vasogenic edema (English)

1 reference

13 November 2017

Yuka Ikegame

1

1 reference

13 November 2017

Kentaro Yamashita

2

1 reference

13 November 2017

Shin-ichiro Hayashi

3

1 reference

13 November 2017

Shin-ichi Yoshimura

4

1 reference

13 November 2017

Shigeru Nakashima

5

1 reference

13 November 2017

Toru Iwama

6

1 reference

13 November 2017

20 May 2010

1 reference

13 November 2017

Hypertension Research

1 reference

13 November 2017

33

1 reference

13 November 2017

7

1 reference

13 November 2017

703-707

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2010.58

13 November 2017

0 references

cites work

Targets for vascular protection after acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

ONO-5046, a novel inhibitor of human neutrophil elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Neutrophil elastase inhibitor attenuates hippocampal neuronal damage after transient forebrain ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

ONO-5046 attenuation of delayed motor neuron death and effect on the induction of brain-derived neurotrophic factor, phosphorylated extracellular signal-regulated kinase, and caspase3 after spinal cord ischemia in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Neutral proteases and disruption of the blood-brain barrier in rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Neutrophil elastase and neurovascular injury following focal stroke and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Protective effect of sivelestat sodium hydrate (ONO-5046) on ischemic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Angiopoietin-1 protects the adult vasculature against plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

Chemokines in ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

7 January 2021

Increase in jugular levels of polymorphonuclear neutrophil elastase in patients with acute cerebral infarction.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

7 January 2021

Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

7 January 2021

Plasma leukocyte elastase concentration in angiographically diagnosed coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.58

7 January 2021

Identifiers

DOI

10.1038/HR.2010.58

1 reference

13 November 2017

1 reference